Somaliland Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Somaliland Health Watch.

Press releases published on August 13, 2026

Aug. 13, 2026

MediPharm Labs Reports Positive Q2 2026 Net Income and Second Consecutive Quarter of Positive Adjusted EBITDA

Indeterminate GlobeNewswire

Aug. 13, 2026

Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

Aug. 13, 2026

Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement

Indeterminate GlobeNewswire

Aug. 13, 2026

ProQR Announces Second Quarter 2026 Operating and Financial Results

Indeterminate GlobeNewswire

Aug. 13, 2026

Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 13, 2026

6 Stress Points That Break Retail Customer Service During Peak Season

Indeterminate GlobeNewswire

Aug. 13, 2026

LENSAR® Reports Second Quarter 2026 Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 13, 2026

Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Indeterminate GlobeNewswire

Aug. 13, 2026

Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer

Indeterminate GlobeNewswire

Aug. 13, 2026

Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2026 Guidance

Indeterminate GlobeNewswire

Aug. 13, 2026

Vireo Growth Inc. Announces Share Buyback Program

Indeterminate GlobeNewswire

Aug. 13, 2026

Sneezing This Season? Weed Pollen Might Be the Reason

Indeterminate GlobeNewswire

Aug. 13, 2026

Montauk Brewing Company Announces New Collaboration with Morning Brew Inc.

Indeterminate GlobeNewswire

Aug. 13, 2026

Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Aug. 13, 2026

Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity

Indeterminate GlobeNewswire

Aug. 13, 2026

Sagimet Biosciences Receives FDA “Study May Proceed” Letter and IND Clearance for Phase 3 Trial in Acne in Adolescent and Adult Patients

Indeterminate GlobeNewswire

Aug. 13, 2026

Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 13, 2026

Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 13, 2026

Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization

Indeterminate GlobeNewswire

Aug. 13, 2026

Zealand Pharma Announces Financial Results for the First Half of 2026

Indeterminate GlobeNewswire